Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gsk Plc ADR
(NY:
GSK
)
42.99
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Mar 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Gsk Plc ADR
< Previous
1
2
3
Next >
ADDING MULTIMEDIA GSK and IQVIA launch Vaccine Track, a data trend platform to help improve adult vaccination in communities nationwide
August 08, 2022
From
GSK plc
Via
Business Wire
GSK Announces US FDA Approval of Benlysta (Belimumab) for Pediatric Patients With Active Lupus Nephritis
July 27, 2022
From
GSK plc
Via
Business Wire
Air Pollution is a Global Heart and Lung Health Concern
July 18, 2022
Palm Beach, FL – July 18, 2022 – FinancialNewsMedia.com News Commentary – Particulate matter or particle pollution is a significant contributor to heart and lung disease. Individuals most affected by...
Via
FinancialNewsMedia
Topics
Climate Change
Emissions
Energy
Exposures
Climate
Fossil Fuels
Watch for Continued Gains in Shares of GlaxoSmithKline PLC (GSK)
April 11, 2022
Via
Investor Brand Network
Watch for Continued Gains in Shares of GlaxoSmithKline PLC (GSK)
April 11, 2022
Via
Investor Brand Network
Watch for Continued Gains in Shares of GlaxoSmithKline PLC (GSK)
January 14, 2022
Via
Investor Brand Network
GSK prepares US for 2022-23 flu season with over 50 million influenza vaccine doses
July 11, 2022
From
GSK plc
Via
Business Wire
GSK Selects Target the Future Grant Recipient in Innovation Challenge Supporting Multiple Myeloma Community
June 29, 2022
From
GSK plc
Via
Business Wire
Breakthroughs In Treating Killer Diseases Could Lengthen Life
June 07, 2022
Palm Beach, FL – June 7, 2022 – FinancialNewsMedia.com News Commentary – According to the World Health Organization, top global killers include heart failure, COPD, cancers, Alzheimer’s, neonatal...
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
GSK announces US FDA approval of PRIORIX for the prevention of measles, mumps and rubella in individuals 12 months of age and older
June 06, 2022
From
GSK plc
Via
Business Wire
Nicotine Surges as Smoking Sags
May 24, 2022
Via
Investor Brand Network
Nicotine Surges as Smoking Sags
May 24, 2022
NetworkNewsWire Editorial Coverage New York, NY – May 24, 2022 – Seems like yesterday people were smoking cigarettes everywhere; many people still have memories of Grandpa puffing on his Camels. It...
Via
FinancialNewsMedia
New Large-Scale Observational Study Shows COVID-19 Could Create Vulnerability to Shingles for People Age 50+
April 06, 2022
From
GSK
Via
Business Wire
Routine Vaccination Rates in Teens and Adults Continue to Lag Behind Pre-Pandemic Levels, Follow-up Analysis Shows
January 21, 2022
From
GSK
Via
Business Wire
Anxious World Waits As Covid Vaccine Makers Address Omicron Variant
December 07, 2021
Palm Beach, FL – December 7, 2021 – FinancialNewsMedia.com News Commentary There are many unknowns surrounding the new omicron Covid variant; there are early signs it’s more transmissible, but it’s not...
Via
FinancialNewsMedia
Exposures
COVID-19
New Covid-19 Vaccines Continue to Be Developed by Biotech Firms Seeking to Improve the Jab
October 06, 2021
FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 6, 2021 – USA News Group – As vaccine passport programs continue to roll out in new markets across the globe, especially in...
Via
FinancialNewsMedia
Exposures
COVID-19
Global Antibiotics Drugs Market: Which Application Willgain the Lion'S Share? with Top Companies Like:Johnson & Johnson, Sanofi-Aventis, Enanta Pharmaceuticals
October 05, 2021
QY Research has used its tons of research and analysis experience and deeper knowledge to comprehensively study the global Antibiotics Drugs market. This report promises sound market understanding for...
Via
SBWire
GSK announces FDA approval for Nucala (mepolizumab) for use in adults with chronic rhinosinusitis with nasal polyps
July 29, 2021
From
GlaxoSmithKline plc
Via
Business Wire
Why Experts Believe Antibody Treatments Hold The Potential To Reduce Need For Hospitalization For COVID-19 Patients
September 14, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Althera Expands Leadership Team in Anticipation of Roszet (rosuvastatin and ezetimibe) Tablets Launch
June 04, 2021
Dr. Patrick Aubonnet appointed as VP, Medical Affairs *** Ed Gutshall appointed as VP, head of Sales *** Dr. James Medley appointed as VP, Regulatory Affairs
Via
EIN Presswire
Why ‘Killer’ T Cells Could Boost COVID Immunity In Face Of New Variants
May 20, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.